SHARE:   Share to Facebook Share to Twitter Share to Linked In Share via Email  

Back To Search Results

C104 - Case Studies: Multiple Sclerosis

Event Time: Monday April 24, 2017 6:00 pm to 9:00 pm
Topic(s): MS and CNS Inflammatory Disease
Director(s): John Corboy MD, FAAN
Description: Diagnostic and treatment issues in multiple sclerosis (MS) and related demyelinating disorders have become more complex, with multiple new treatment options. Through presentations of common and more challenging cases, faculty will facilitate a discussion on differential diagnosis, laboratory and MRI evaluation, ethical issues, and treatment of MS and related conditions. Each case will be followed by an overview and update on the topic.
Completion Message: Participants should be familiar with the differential diagnoses, work-up, and treatment of MS and related conditions, including interpretation of MRI studies for MS and other disorders that affect the brain and spinal cord.
CME Credits: 3
Core Competencies: Medical Knowledge, Patient Care, Practice-Based Learning and Improvement

Program Speakers - Tentative

Start/End Time Title Faculty
6:00 PM - 7:15 PM Cases Enrique Alvarez MD, PhD, John Corboy MD, FAAN, Mary Willis MD 
7:15 PM - 7:30 PM Break None  
7:30 PM - 8:45 PM Cases Enrique Alvarez MD, PhD, John Corboy MD, FAAN, Mary Willis MD 
8:45 PM - 9:00 PM Questions and Answers Faculty 

Disclosures

Speaker Disclosure
Enrique Alvarez, MD, PhD Dr. Alvarez has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Actelion, Biogen, Celgene, EMDSerono, Genzyme, Genentech, Novartis, Teva, and TG pharmaceuticals. Dr. Alvarez has received research support from Acorda, Biogen, Genentech, Novartis, and Rocky Mountain MS Center.

John Corboy, MD, FAAN Dr. Corboy has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Prime CME. Dr. Corboy has received personal compensation in an editorial capacity for American Academy of Neurology. Dr. Corboy has received research support from Med Day, Novartis, Biogen.

Mary Alissa Willis, MD Dr. Willis has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Biogen, Genzyme.

Register Now

Related Courses

Saturday April 21, 2018

9:30 AM-11:30 AM
C11 Treatment of Pediatric Multiple Sclerosis in the Current Era Brenda Banwell MD, FAAN

Sunday April 22, 2018

7:00 AM-9:00 AM
C33 Multiple Sclerosis in the Trenches: Controversy and Consensus in Clinical Decision-Making Aaron Miller MD, FAAN
3:30 PM-5:30 PM
C57 Spanish: Update on MS Therapy Lilyana Amezcua MD

Tuesday April 24, 2018

7:00 AM-9:00 AM
C97 Multiple Sclerosis Overview I: Clinical Pearls John Corboy MD, FAAN
1:00 PM-3:00 PM
C107 Multiple Sclerosis Overview II: Clinical Advances Scott Newsome DO, FAAN
3:30 PM-5:30 PM
C121 Multiple Sclerosis Overview III: Basic and Translational Science Michael Racke MD

Wednesday April 25, 2018

7:00 AM-9:00 AM
C135 Multiple Sclerosis Therapy: Disease-modifying Treatment I David Jones MD
9:15 AM-11:30 AM
PL5 Frontiers in Neuroscience Plenary Session
1:00 PM-3:00 PM
C146 Multiple Sclerosis Therapy: Disease-modifying Treatment II John Rose MD, FAAN
3:30 PM-5:30 PM
C161 Multiple Sclerosis Therapy: Symptom Management Jonathan Carter MD

Thursday April 26, 2018

7:00 AM-9:00 AM
C174 Clinical Pearls in Autoimmune Neurology: Real World Cases Stacey Clardy MD, PhD
1:00 PM-3:00 PM
N5 Neuroscience in the Clinic: Treatment of Progressive Multiple Sclerosis Eric Klawiter MD,
Ellen Mowry MD, FAAN

Friday April 27, 2018

1:00 PM-3:00 PM
C223 Neuromyelitis Optica Spectrum Disorders Dean Wingerchuk MD, FAAN

MEMBER LOG IN

Forgot Password?